Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Theilacker

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
Vaccine|July 23, 2019
Rethinking results from the Japanese 23-valent pneumococcal polysaccharide vaccine randomized clinical trialBradford D Gessner, Christian Theilacker, Luis Jodar
Clinical and Diagnostic Laboratory Immunology|August 9, 2005
Naturally acquired antibodies against four Enterococcus faecalis capsular polysaccharides in healthy human seraMarkus Hufnagel, Andrea Kropec, Christian Theilacker, et al.
Vaccine|March 26, 2004
Enterococcal infections: host response, therapeutic, and prophylactic possibilitiesStefanie Koch, Markus Hufnagel, Christian Theilacker, et al.
Vaccine|December 4, 2004
Rationale for the development of immunotherapy regimens against enterococcal infectionsChristian Theilacker, Wolfgang A Krueger, Andrea Kropec, et al.
Microorganisms|May 28, 2022
Correction: Theilacker et al. PCV13 Vaccination of Adults against Pneumococcal Disease: What We Have Learned from the Community-Acquired Pneumonia Immunization Trial in Adults (CAPiTA). <i>Microorganisms</i> 2022, <i>10</i>, 127Christian Theilacker, Mark A Fletcher, Luis Jodar, et al.
Microorganisms|January 21, 2022
PCV13 Vaccination of Adults against Pneumococcal Disease: What We Have Learned from the Community-Acquired Pneumonia Immunization Trial in Adults (CAPiTA)Christian Theilacker, Mark A Fletcher, Luis Jodar, et al.
Carbohydrate Research|May 4, 2012
The structure of the wall teichoic acid isolated from Enterococcus faecalis strain 12030Christian Theilacker, Otto Holst, Buko Lindner, et al.
BMC Health Services Research|January 16, 2019
Burden of community-acquired pneumonia, predisposing factors and health-care related costs in patients with cancerNiklas Schmedt, Olivia Denise Heuer, Dennis Häckl, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 19, 2012
Natural antibodies in normal human serum inhibit Staphylococcus aureus capsular polysaccharide vaccine efficacyDavid Skurnik, Andrea Kropec, Damien Roux, et al.
Infection and Immunity|June 24, 2003
Construction and characterization of a Pseudomonas aeruginosa mucoid exopolysaccharide-alginate conjugate vaccineChristian Theilacker, Fadie T Coleman, Simone Mueschenborn, et al.
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
Vaccine|July 23, 2019
Rethinking results from the Japanese 23-valent pneumococcal polysaccharide vaccine randomized clinical trialBradford D Gessner, Christian Theilacker, Luis Jodar
Clinical and Diagnostic Laboratory Immunology|August 9, 2005
Naturally acquired antibodies against four Enterococcus faecalis capsular polysaccharides in healthy human seraMarkus Hufnagel, Andrea Kropec, Christian Theilacker, et al.
Vaccine|March 26, 2004
Enterococcal infections: host response, therapeutic, and prophylactic possibilitiesStefanie Koch, Markus Hufnagel, Christian Theilacker, et al.
Vaccine|December 4, 2004
Rationale for the development of immunotherapy regimens against enterococcal infectionsChristian Theilacker, Wolfgang A Krueger, Andrea Kropec, et al.
Microorganisms|May 28, 2022
Correction: Theilacker et al. PCV13 Vaccination of Adults against Pneumococcal Disease: What We Have Learned from the Community-Acquired Pneumonia Immunization Trial in Adults (CAPiTA). <i>Microorganisms</i> 2022, <i>10</i>, 127Christian Theilacker, Mark A Fletcher, Luis Jodar, et al.
Microorganisms|January 21, 2022
PCV13 Vaccination of Adults against Pneumococcal Disease: What We Have Learned from the Community-Acquired Pneumonia Immunization Trial in Adults (CAPiTA)Christian Theilacker, Mark A Fletcher, Luis Jodar, et al.
Carbohydrate Research|May 4, 2012
The structure of the wall teichoic acid isolated from Enterococcus faecalis strain 12030Christian Theilacker, Otto Holst, Buko Lindner, et al.
BMC Health Services Research|January 16, 2019
Burden of community-acquired pneumonia, predisposing factors and health-care related costs in patients with cancerNiklas Schmedt, Olivia Denise Heuer, Dennis Häckl, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 19, 2012
Natural antibodies in normal human serum inhibit Staphylococcus aureus capsular polysaccharide vaccine efficacyDavid Skurnik, Andrea Kropec, Damien Roux, et al.
Infection and Immunity|June 24, 2003
Construction and characterization of a Pseudomonas aeruginosa mucoid exopolysaccharide-alginate conjugate vaccineChristian Theilacker, Fadie T Coleman, Simone Mueschenborn, et al.
Pageof 7